Opendata, web and dolomites

NIRT MONITOR SIGNED

ACCURATE EASY-TO-USE AND NON-INVASIVE DEVICE FOR EARLY DETECTION AND MONITORING OF HEART FAILURE IN REAL TIME

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NIRT MONITOR project word cloud

Explore the words cloud of the NIRT MONITOR project. It provides you a very rough idea of what is the project "NIRT MONITOR" about.

diastolic    coralert    validated    estimate    annually    procedure    heart    life    monitor    market    80    lvedp    later    performed    11    solution    invasive    prevention    countries    nirt    reducing    commercial    patients    decrease    offices    gp    financial    disposables    units    admissions    ventricular    time    100    gold    device    feasibility    catheterization    clinical    hospitals    payment    medical    inexpensive    billion    leasing    left    spent    measuring    spain    acute    internal    medicine    physicians    release    cardiology    save    distributors    germany    profit    indirect    complexes    cloud    fees    alternative    accuracy    lab    assay    safety    quality    app    uses    hf    30    commercialization    risky    standard    diagnosing    innovative    safe    adopters    sales    pressure    business    icu    homecare       filled    expansion    revenues    treatment    healthcare    patent    europeans    diagnosis    asymp    38    pct    efficient    catheter    sme    complications    er    france    41    patient    direct    settings    penetration    roi    share    model    sucessful    5m    15    offers    hospitalizations    re    first    million   

Project "NIRT MONITOR" data sheet

The following table provides information about the project.

Coordinator
CORALERT LTD 

Organization address
address: TCHELET 17
city: MISGAV
postcode: 2017400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://coralertmed.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CORALERT LTD IL (MISGAV) coordinator 50˙000.00

Map

 Project objective

Heart Failure (HF) affects 15 million of Europeans and €6.41 billion are annually spent on its management and treatment by the healthcare system, CORALERT aims to favour the HF prevention and decrease its costs through its innovative NIRT MONITOR medical device. Gold standard procedures for diagnosing HF using catheterization are risky and complexes. As validated by clinical assay, NIRT MONITOR offers an alternative, safe and easy to use method to early diagnosis HF in real time by non-invasive measuring of LVEDP (Left Ventricular End Diastolic Pressure) providing physicians and in- and out-patient settings an early diagnosis of HF and its complications. NIRT MONITOR will improve the quality of life of patients while reducing hospitalizations by 30% and re-admissions by 80%. Cardiology, ICU, ER and Internal Medicine Units from hospitals (€5.1 billion of European market), GP offices and homecare settings will be the target users. NIRT MONITOR business model will be based on devices sales/leasing for early adopters and later from indirect sales/leasing through medical technology distributors. Revenues will be also generated by direct and indirect sales of disposables and by Cloud App payment fees. NIRT MONITOR will be an inexpensive solution (€10,000/device) in comparison with one catheter lab procedure (first two uses will save the 100% of the costs of one use of the standard method). NIRT MONITOR´s safety, easy to use, cost-efficient and accuracy will ensure its penetration into targeted European countries (Spain, France and Germany) and expansion over other European countries and US. We estimate a profit of ≈€38.5M after four years of commercialization with a ROI of 11.8 and a market share of 4.5%. We have filled US and PCT patent applications. To ensure the sucessful release of NIRT MONITOR into the market, a feasibility study will be performed during SME Phase 1 to evaluate any technical, commercial and financial issues related to the project.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NIRT MONITOR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NIRT MONITOR" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

SmartDegrees (2020)

First anti-fraud plataform for the registration and certification of diplomas and academic certificates based in blockchain

Read More  

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More